Human Liver Model Market By Type (In vitro models, In vivo models, Computational models), By Application (Drug discovery & development, Disease modelling, Regenerative medicine, Educational & training, Others), By Model (2D liver models, 3D liver models), By Technology (3D bioprinting technology, Liver-on-chip technology, Stem cell-based liver models, Computational modelling & simulation), By End-User (Pharmaceutical & biotechnology companies, Academic & research institutions, Hospitals & clinical research centers, Contract research organizations (CROs), Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Type

• In vitro models
• In vivo models
• Computational models

By Application

• Drug discovery & development
• Disease modelling
• Regenerative medicine
• Educational & training
• Others

By Model

• 2D liver models
• 3D liver models

By Technology

• 3D bioprinting technology
• liver-on-chip technology
• Stem cell-based liver models
• Computational modelling & simulation

By End-User

• Pharmaceutical & biotechnology companies
• Academic & research institutions
• Hospitals & clinical research centers
• Contract research organizations (CROs)
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• ATCC
• Merck KGaA
• AcceGen
• ZenBio, Inc.
• Organovo Holdings Inc.
• BioIVT
• InSphero
• Emulate, Inc.
• Mimetas
• CN Bio Innovations Ltd
• Corning Incorporated
• Cyprotex
• Cellink
• Hurel Corporation
• Cyfuse Biomedical K.K.